Summary of Information about License Rights and Other Intangible Assets, Net |
The following provides information about our license rights and other intangible assets, net (in thousands):
|
|
September 30, 2021 |
|
|
December 31, 2020 |
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
|
|
|
|
|
Amount |
|
|
Amortization |
|
|
Net |
|
|
Amount |
|
|
Amortization |
|
|
Net |
|
Licensed rights and intangible assets
subject to amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License rights |
|
$ |
40,000 |
|
|
$ |
6,070 |
|
|
$ |
33,930 |
|
|
$ |
40,000 |
|
|
$ |
3,803 |
|
|
$ |
36,197 |
|
Hormone therapy drug patents |
|
|
4,732 |
|
|
|
985 |
|
|
|
3,747 |
|
|
|
4,045 |
|
|
|
749 |
|
|
|
3,296 |
|
Hormone therapy drug patents applied
and pending approval |
|
|
1,596 |
|
|
|
— |
|
|
|
1,596 |
|
|
|
1,629 |
|
|
|
— |
|
|
|
1,629 |
|
License rights and other intangible assets
subject to amortization |
|
|
46,328 |
|
|
|
7,055 |
|
|
|
39,273 |
|
|
|
45,674 |
|
|
|
4,552 |
|
|
|
41,122 |
|
Intangible assets not subject to amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trademarks/trade name rights |
|
|
344 |
|
|
|
— |
|
|
|
344 |
|
|
|
323 |
|
|
|
— |
|
|
|
323 |
|
License rights and other intangible assets, net |
|
$ |
46,672 |
|
|
$ |
7,055 |
|
|
$ |
39,617 |
|
|
$ |
45,997 |
|
|
$ |
4,552 |
|
|
$ |
41,445 |
|
|